What is Hims?
Hims & Hers Health, Inc. trades on the NYSE as HIMS and was incorporated in Delaware in July 2017, reaching the public market through a merger with the shell company Oaktree Acquisition Corp. It is the largest company in this collection and the only one that owns most of its own supply chain: its annual report lists two licensed 503A pharmacies, two UK-licensed pharmacies, a 503B compounding outsourcing facility, a peptide manufacturing plant and a laboratory. On nine other pages here the biggest unanswered question is which pharmacy fills your prescription. Hims answers it in an SEC filing, because it has to.
That public filing obligation is why this review looks different from the others. In March 2026 Hims announced what it calls a strategic shift, moving its US weight-loss business to brand-name GLP-1s and keeping compounded access only, in its words, on a limited scale. It booked $38 million in restructuring charges in the first half of 2026 doing it. The cause is traceable in the same filings: the FDA declared the semaglutide shortage resolved in February 2025, and that resolution narrowed the legal basis for using outsourcing facilities to supply compounded semaglutide at scale. Every compounded-GLP-1 seller on this site faced that. Hims is the only one that had to put a number on what it cost.
What that leaves is the widest brand-name menu we have found: Wegovy as a pill, a pen and a microdosing plan, Zepbound as a vial and a KwikPen, Ozempic as a pill and a pen, the oral Foundayo, and Mounjaro. Three of those are pills, which matters if you do not want to inject, and no competitor here offers three brand-name orals. Hims discloses that Ozempic and Mounjaro are approved for type 2 diabetes and available only to patients meeting clinical criteria, so a weight-loss prescription for either is off-label.
How much does Hims actually cost?
Hims charges twice. The membership is $39 for the first month and $149 a month after that, and the medication is billed separately on top. The medication price is what varies, from $149 a month for a starting-dose pill to $1,899 a month for a brand autoinjector, so your all-in runs from about $298 to about $2,048. Those two totals are our arithmetic on Hims' published figures, because Hims does not print a combined number anywhere. Nothing on this page was verifiable before now: hims.com refuses automated requests, which is why every price in the previous version of this review carried a placeholder. It all reads normally in a browser.
| Medication | Form | Advertised | What you'll actually pay |
|---|---|---|---|
| Wegovy pill, or its microdosing plan | Daily tablet | From $149/mo | About $298/mo with the membership |
| Foundayo pill, or the Ozempic pill | Daily tablet | From $149/mo | About $298/mo with the membership |
| Wegovy pen | Weekly injection | From $199/mo | Plus the membership, and more at higher doses |
| Zepbound vial or KwikPen | Weekly injection | From $299/mo | Plus the membership |
| Mounjaro, or the Zepbound autoinjector | Weekly injection | $1,899/mo | About $2,048/mo with the membership |
Prices checked August 12, 2026 against Hims's published pricing. Compounded medications are not FDA-approved.
What's included
- Access to GLP-1 medication, if a provider prescribes it
- 24/7 care team access and provider messaging
- Nutrition and exercise guidance in the app
What costs extra
- The medication, which is always a separate charge
- Any guarantee of a prescription, which the membership explicitly does not provide
- Insurance billing, since Hims does not accept insurance for weight loss
Cancellation and refunds
This is the part to read twice, because it is the subject of a live federal lawsuit. Hims states on its own pricing page that membership is required, is billed separately, and does not include or guarantee a prescription, so you can pay and be declined. The refund policy the BBB reproduces for Hims says all sales and payments are final, irrevocable and not eligible for a refund, and that Hims does not accept returns; we have not read that on hims.com ourselves, so treat it as the policy BBB publishes rather than a quotation from the company. And in July 2026 the FTC, the Utah Division of Consumer Protection and Los Angeles County sued Hims over its subscription and cancellation practices. Whatever the outcome, the practical advice is the same: screenshot the terms you agree to, cancel in writing, and keep the confirmation.
One number deserves singling out. The Zepbound vial and KwikPen are $299 a month, and the Zepbound autoinjector is $1,899 a month. That is the same molecule at roughly six times the price, differing by device, and Mounjaro is listed at $1,899 too. Those are list prices rather than manufacturer-program prices, so before paying $2,048 a month all-in for either, price the drug at LillyDirect directly. Prices verified against hims.com on August 12, 2026, in a browser, because the site refuses automated requests.
$39 first month, then $149/mo membership, billed separately from the medication
What medications does Hims offer?
Compounded medications contain the same active ingredients as their brand-name versions but are not FDA-approved. Each medication link above goes to our full guide on that drug.
How Hims works
-
Online questionnaire
A health history and eligibility questionnaire, with no appointment.
-
Pay for membership
$39 for the first month, renewing at $149. Hims says plainly that this does not include or guarantee a prescription, and that medication is not available without it. So the fee comes before the answer.
-
Provider review
A licensed provider reviews your intake and decides whether to prescribe, and which product fits.
-
Its own pharmacy fills it
Hims owns two 503A pharmacies and a 503B outsourcing facility, so fulfillment is generally in-house rather than through a partner nobody will name.
-
Ongoing care
Refills, dose changes and messaging run through the app. If you are on a pill rather than an injection, this is one of the few providers where that is a first-class option rather than an afterthought.
Who qualifies
- Adults who meet a provider's criteria for weight-management medication
- Cash payers, since Hims does not bill insurance for weight loss
- People who specifically want a brand-name oral GLP-1
Who shouldn't use it
- Anyone with a personal or family history of medullary thyroid carcinoma or MEN 2
- People who are pregnant, planning a pregnancy, or breastfeeding
- Anyone shopping for compounded medication, which is no longer on the menu
A licensed clinician always makes the final call. Read the full GLP-1 safety information →
Is Hims legit?
Hims is the one provider here whose record you can read in full, and that cuts both ways. Because it is publicly traded it must disclose regulatory and legal exposure that its private competitors never have to mention, and what it discloses is the largest such record in this collection: two FDA warning letters, a warning letter to its own outsourcing facility, an FDA statement naming it, an SEC enforcement investigation, a securities class action, and a live FTC lawsuit. Read that with two things in mind. Almost none of it concerns the safety of the brand-name, FDA-approved medication it sells today, and a private competitor with the same problems would simply not be telling you.
Licensed providers review intake and prescribe at their discretion. Hims is explicit that paying for membership does not guarantee a prescription, which is honest about the gate even though it means paying before you know.
Hims answers the pharmacy question more fully than anyone else here, and then its own filing shows the risk of owning the answer. Its annual report lists two licensed 503A pharmacies, two UK-licensed pharmacies, a 503B compounding outsourcing facility, a peptide manufacturing facility and a laboratory. That vertical integration is why Hims could scale compounded semaglutide faster than anyone in 2024 and 2025. It is also why, in December 2025, FDA sent a warning letter to that outsourcing facility over a failure to submit an adverse event report and deficiencies in its adverse-event reporting procedures. Hims says it responded on time. Of everything on this page, that is the item most directly about patient safety rather than marketing or money.
Lawsuit · 2026
On July 29, 2026 the Federal Trade Commission, together with the Utah Division of Consumer Protection and Los Angeles County on behalf of the People of California, sued Hims in the Northern District of California. The complaint alleges violations of Section 5 of the FTC Act and of the Restore Online Shoppers' Confidence Act, the federal statute governing online subscriptions and negative-option billing, and seeks a permanent injunction, monetary relief and civil penalties. It follows a Civil Investigative Demand issued in October 2023 into Hims' privacy, advertising, subscription and cancellation practices, after settlement talks failed. As of June 30, 2026 Hims had recorded a legal contingency accrual of approximately $60 million for the matter, and says it has meritorious arguments and will defend vigorously. A putative privacy class action, Doe v. Hims & Hers Health, was filed on substantially the same facts. Nothing has been decided. We are flagging it because cancellation difficulty is the single most common complaint about every provider on this site, and this is the one instance where a regulator has put that complaint into a federal court filing.
Read the primary source →FDA warning letter · 2025
On September 9, 2025 the FDA sent two warning letters to Hims' chief executive, one for hims.com and one for forhers.com. Having reviewed both sites in August 2025, the agency found the compounded semaglutide sold through them misbranded because specific claims implied it was the same as an approved drug: it cites "Same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients". Be clear what this is and is not. It is a finding about marketing claims, not a finding that Hims sold contaminated or counterfeit medicine. It is also not unique to Hims: FDA issued Remedy Meds a letter the same day, so this was one telehealth enforcement sweep. Separately, in December 2025 Hims' own 503B outsourcing facility received a warning letter over failing to submit an adverse event report, which Hims says it answered on time, and in February 2026 the FDA named Hims in a statement about restricting GLP-1 ingredients used in compounded copies of approved drugs.
Read the primary source →In the news · 2026
Four further matters, all from Hims' own filings, and all about what it told investors or how it marketed rather than about patient care. In February 2026 the SEC's Division of Enforcement opened an investigation into Hims' public statements about compounded semaglutide and related business relationships; it is ongoing. A consolidated securities class action alleges Hims misled shareholders about its relationship with Novo Nordisk during a two-month window in 2025, with three related derivative suits stayed. Novo Nordisk itself sued Hims for patent infringement over compounded semaglutide in February 2026 and voluntarily withdrew the case a month later, so no court ruled on it. And in February 2026 the general counsel of the Department of Health and Human Services said publicly that HHS had referred Hims to the Department of Justice for investigation of potential violations of federal food and drug law and the federal criminal code. To be precise about that last one, because the distinction matters: what is on the record is a statement that a referral for investigation was made. No charges have been filed, and Hims says it cannot predict what if anything results.
Read the primary source →Verify it yourself
- Read the FDA warning letter to Hims yourself →
- Read the parallel letter issued to the Hers brand the same day →
- Read the 10-Q legal proceedings note, which is the source for most of this section →
- Read the annual report, including the list of pharmacies and facilities →
- Read Hims' BBB profile, which carries no rating →
Protect yourself: what to check at checkout & on the label
Compounded GLP-1s ship without the packaging you’d get from a pharmacy chain, and the advertised price is rarely the real one. Before you pay Hims, and when your order arrives, verify:
On the checkout screen
- The recurring charge and its cadence. Separate the membership fee from the medication price so a “$99” plan isn’t silently $178/mo.
- Every add-on line item: consultation, lab work, shipping, and dose-increase surcharges.
- The cancellation terms and next bill date, shown before you confirm. Screenshot this.
- A clear order confirmation with an itemized total, not just a “welcome” email.
On the compounded label
- The compounding pharmacy’s name and state license. Then confirm it on LegitScript or the state board.
- Active ingredient and strength (e.g. “semaglutide 2.5 mg/mL”). It should match what you were prescribed.
- A beyond-use / discard-by date and a lot number. Sterile compounds are dated; a missing date is a red flag.
- The prescribing clinician’s name, a real prescriber, not just the brand.
What real users say about Hims
What users praise
- A fast, polished signup, which is what most positive reviews describe
- Genuine pill options, for people who will not inject
- A competitive entry price for a brand-name drug
What users complain about
- Cancellation and refunds, which Trustpilot's own topic extraction ranks near the top
- Subscription billing, now the subject of the FTC's complaint
- Price escalating with dose, which reviewers describe as feeling baited
Individual reviews can't establish medication quality or predict your results. Treat them as a read on the company's operations, not the drug.
Does Hims take insurance?
Hims does not bill insurance for weight loss. The membership and the medication are both cash-pay, which makes the comparison simple: about $298 a month all-in for a starting-dose pill, rising with your dose and rising steeply if you want a brand autoinjector. If your plan covers a GLP-1, a provider that fights prior authorization for you will almost certainly beat this, and Calibrate or Ro are the pages to read instead.
If you are paying cash for a brand-name drug, compare Hims against the manufacturers' own programs before you commit. The $299 Zepbound vial and KwikPen are competitive. The $1,899 autoinjector prices for Mounjaro and Zepbound are list prices, and paying them through Hims means about $2,048 a month once the membership is counted. Nobody should pay that without first checking what LillyDirect charges for the same medication.
Hims vs the alternatives
| Provider | From | Medications | Best for |
|---|---|---|---|
| Ro | $39 first month, then $298/mo all-in | Brand-name GLP-1s at manufacturer prices | Manufacturer-priced brand-name meds |
| Calibrate | $199/mo, 3-month minimum | Brand-name GLP-1s only | Brand-name only, no compounding |
| LifeMD | $39 first month, then $149/mo | Brand and compounded GLP-1s | Brand-name medication through insurance |
Final verdict
Choose Hims if…
- You want a brand-name oral GLP-1, where Hims has the widest choice on this site
- You would rather buy from a company whose regulatory problems are filed and readable
- You want the pharmacy that fills your prescription to be named and licensed
- About $298 a month all-in for a starting dose fits your budget
Skip it if…
- You wanted compounded medication, which has come off the menu
- Your insurance covers a GLP-1, because Hims will not bill it
- You are looking at Mounjaro or the Zepbound autoinjector, at roughly $2,048/mo all-in
- A live FTC lawsuit about cancellation practices is disqualifying for you
Judge Hims on two separate questions and the answers differ. As a way to buy a brand-name GLP-1 it is strong: ten products, three of them pills, its own licensed pharmacies, and about $298 a month all-in at a starting dose. As a company to hand a recurring payment to, it is the most legally embattled provider on this site, and the specific thing regulators are suing about is how it handles subscriptions and cancellations. Both facts are real, and the second is only visible because Hims is public and has to tell you. If you sign up, buy the pill rather than the $1,899 autoinjector, check LillyDirect first, and treat the cancellation terms as the part that matters.
$39 first month, then $149/mo membership, billed separately from the medication
Hims FAQ
How much does Hims cost per month?
Two charges. The membership is $39 for the first month and $149 a month after, and the medication is separate. Medication runs from $149 a month for a starting-dose pill to $1,899 for a brand autoinjector, so all-in you are looking at roughly $298 a month at the low end and about $2,048 at the high end. Those totals are our arithmetic on Hims' published figures, because Hims never prints a combined number.
Does Hims still sell compounded semaglutide?
Not on its published menu, which is now entirely brand-name. In March 2026 Hims announced a shift to branded GLP-1s and said it would keep offering compounded access only on a limited scale, and it booked $38 million in restructuring charges in the first half of 2026 making the change. So the honest answer is that compounded is off the menu but not formally ended. If it matters to you either way, ask before you pay.
Why did the FDA send Hims warning letters?
On September 9, 2025 the FDA sent two letters, one for hims.com and one for forhers.com, to Hims' chief executive. Having reviewed both sites, the agency said claims about the compounded semaglutide sold there were false or misleading because they implied the product was the same as an approved drug, specifically "Same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients". That makes the products misbranded under federal law. It is a finding about marketing, not about the drug being unsafe or fake, and FDA sent Remedy Meds a letter the same day, so Hims was one target of a broader telehealth sweep.
Is the FTC suing Hims?
Yes. On July 29, 2026 the FTC, the Utah Division of Consumer Protection and Los Angeles County sued Hims in federal court in California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act, which governs online subscriptions and auto-renewal. They are seeking an injunction, money and civil penalties. Hims has set aside about $60 million for the case and says it will defend itself. Nothing has been decided. It grew out of an FTC investigation opened in October 2023 into Hims' privacy, advertising, subscription and cancellation practices.
Was Hims referred to the Department of Justice?
Hims discloses that in February 2026 the general counsel of Health and Human Services stated publicly that HHS had referred the company to the DOJ for investigation of potential violations of federal food and drug law and the federal criminal code. That is the whole of what is on the record: a statement that a referral for investigation was made. No charges have been filed, no case has been brought, and Hims says it cannot predict whether anything will follow. We report it because Hims reports it, and we will not characterize it beyond that.
What pharmacy does Hims use?
Its own, and it is one of the few providers that says so. Hims' annual report lists two licensed 503A pharmacies, two UK-licensed pharmacies, a 503B compounding outsourcing facility, a peptide manufacturing facility and a laboratory. The trade-off appeared in December 2025, when that 503B facility received an FDA warning letter over failing to submit an adverse event report and deficiencies in its reporting procedures. Hims says it responded on time.
Does Hims take insurance?
No, not for weight loss. Both the membership and the medication are cash-pay. If your plan covers a GLP-1, you will do better with a provider that files prior authorization for you.
Why is Trustpilot so low if Hims is the biggest brand?
Hims scores 3.0 across 9,000 reviews, the lowest of any provider we review, with 2,222 reviews in the past year so it is current rather than historical. It is also the only provider here whose five-star share is under half, at 39%, with 29% one-star. Trustpilot's own topic extraction puts cancellation, refund and subscription among the leading themes, which is the same thing the FTC is suing about. Its BBB profile is the odd one out: 4,333 complaints, no rating at all, and yet a 3.71 review average across 6,577 reviews, higher than Trustpilot. We think that reflects Hims soliciting reviews on BBB at scale, which is worth knowing before you read either number as a verdict.
Sources
- Hims, weight-loss products and pricing (accessed August 12, 2026)
- Hims & Hers Health, Inc., Form 10-Q for the quarter ended June 30, 2026, legal proceedings and risk factors (accessed August 12, 2026)
- Hims & Hers Health, Inc., Form 10-K for the year ended December 31, 2025 (accessed August 12, 2026)
- FDA warning letter, Hims & Hers Health, Inc. dba Hims, MARCS-CMS 716567, September 9, 2025 (accessed August 12, 2026)
- FDA warning letter, Hims & Hers Health, Inc. dba Hers, MARCS-CMS 716825, September 9, 2025 (accessed August 12, 2026)
- Hims & Hers Health, Inc., BBB business profile (accessed August 12, 2026)
- Hims on Trustpilot (accessed August 12, 2026)
This review is for information only and isn't medical advice. Talk to a licensed clinician about whether any GLP-1 medication is right for you. Compounded medications are not FDA-approved. We're independent: we don't sell medication, and commissions never affect our verdicts. Editorial policy · Medical disclaimer · GLP-1 safety information